Attenuation of hyperalgesia by LY235959, a competitive N-methyl-d-aspartate receptor antagonist

This publication has 11 references indexed in Scilit:

• Preclinical Evidence for a Role of Glutamatergic Systems in Opioid Tolerance and Dependence
  Seminars in Neuroscience, 1997
• The utility of excitatory amino acid (EAA) antagonists as analgesic agents. I. Comparison of the antinociceptive activity of various classes of EAA antagonists in mechanical, thermal and chemical nociceptive tests
  Pain, 1994
• Cloned Glutamate Receptors
  Annual Review of Neuroscience, 1994
• The nature and time course of neuronal vacuolation induced by the N-methyl-D-aspartate antagonist MK-801
  Acta Neuropathologica, 1994
• The NMDA Receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids
  Pain, 1994
• Unusual stereochemical preferences of decahydroisoquinoline-3-cargoxylic acid competitive NMDA antagonists
  Bioorganic & Medicinal Chemistry Letters, 1993
• Pharmacological Evidence for Involvement of Excitatory Amino Acids in Aversive Responses Induced by Intrathecal Substance P in Rats.
  Biological & Pharmaceutical Bulletin, 1993
• Neuroprotectant effects of LY 274614, a structurally novel systemically active competitive NMDA receptor antagonist
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1991
• NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal
  European Journal of Pharmacology, 1991
• Pathological Changes Induced in Cerebrocortical Neurons by Phencyclidine and Related Drugs
  Science, 1989